UBS O'Connor’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

UBS O'Connor’s Portfolio OACC Stock Details OACC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$3.17M	Hold	300,000	–	–	0.09%	73
2025 Q3	$3.15M	Buy	300,000 +100,000	+50%	+$1.04M	0.1%	93
2025 Q2	$2.1M	Sell	200,000 -250,000	-56%	-$2.59M	0.06%	151
2025 Q1	$4.6M	Hold	450,000	–	–	0.11%	70
2024 Q4	$4.48M	Buy	+450,000	New	+$4.49M	0.11%	91

Other funds holding OACC

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Empyrean Capital Partners Los Angeles, California $3B AUM 34.24% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Boussard & Gavaudan Investment Management London, United Kingdom $1.04B AUM 4.58% 1-Year Est. Return

Decagon Asset Management London, United Kingdom $385M AUM 45.42% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

HighTower Advisors

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return